MedPath

CALCITONIN SALMON

These highlights do not include all the information needed to use CALCITONIN SALMON NASAL SOLUTION (Calcitonin Salmon Nasal Spray) safely and effectively. See full prescribing information for CALCITONIN SALMON NASAL SOLUTION (Calcitonin Salmon Nasal Spray), for Intranasal Use Only ().Initial U.S. Approval: 1975

Approved
Approval ID

a6eaedb3-5c96-4859-be43-a48c9c818bc7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 30, 2019

Manufacturers
FDA

Par Pharmaceutical, Inc.

DUNS: 092733690

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

CALCITONIN SALMON

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code49884-161
Application NumberANDA076979
Product Classification
M
Marketing Category
C73584
G
Generic Name
CALCITONIN SALMON
Product Specifications
Route of AdministrationNASAL
Effective DateMarch 30, 2019
FDA Product Classification

INGREDIENTS (5)

NITROGENInactive
Code: N762921K75
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
CALCITONIN SALMONActive
Quantity: 200 [iU] in 0.09 mL
Code: 7SFC6U2VI5
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CALCITONIN SALMON - FDA Drug Approval Details